Proffitt & Goodson’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$826K Hold
689
0.11% 79
2026
Q1
$634K Sell
689
-11
-2% -$11.2K 0.1% 84
2025
Q4
$752K Sell
700
-17
-2% -$16.3K 0.1% 76
2025
Q3
$547K Buy
717
+17
+2% +$12.7K 0.08% 84
2025
Q2
$546K Buy
700
+667
+2,021% +$518K 0.08% 84
2025
Q1
$27.3K Hold
33
﹤0.01% 183
2024
Q4
$25.5K Sell
33
-6
-15% -$4.97K ﹤0.01% 178
2024
Q3
$34.6K Sell
39
-20
-34% -$18K 0.01% 183
2024
Q2
$53.4K Buy
+59
New +$47.2K 0.01% 161
2021
Q1
Sell
-20
Closed -$3K 263
2020
Q4
$3K Sell
20
-140
-88% -$20.9K ﹤0.01% 234
2020
Q3
$24K Hold
160
0.01% 166
2020
Q2
$26K Hold
160
0.01% 167
2020
Q1
$22K Hold
160
0.01% 142
2019
Q4
$21K Hold
160
﹤0.01% 145
2019
Q3
$18K Hold
160
﹤0.01% 151
2019
Q2
$18K Hold
160
﹤0.01% 142
2019
Q1
$21K Buy
160
+20
+14% +$2.43K 0.01% 136
2018
Q4
$16K Hold
140
﹤0.01% 112
2018
Q3
$15K Buy
+140
New +$14K ﹤0.01% 106

Other funds holding LLY

Proffitt & Goodson's LLY Position: Q2 2026 in Review

Proffitt & Goodson held its Eli Lilly (LLY) position steady in Q2 2026 at 689 shares worth $826K. The position accounts for 0.11% of the portfolio, ranked #79.

Proffitt & Goodson first reported a position in LLY in Q3 2018 and has held it in 19 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Proffitt & Goodson held 689 shares of Eli Lilly worth $826K as of Q2 2026.
  • Proffitt & Goodson left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.11% of Proffitt & Goodson's portfolio in Q2 2026, its #79 holding.
  • Proffitt & Goodson first reported a position in Eli Lilly in Q3 2018 and has held it in 19 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Proffitt & Goodson's 13F filing for Q2 2026, filed 22 Jul 2026.